CBD (cannabidiol) is the newest cannabinoid derived from industrial hemp and cannabis, taking center stage.
All mammals have an endocannabinoid system (ECS) – including our pets.
Because cannabinoids like cannabidiol (CBD) positively interact with this vastly intricate system, and the ECS plays a role in regulating and monitoring our nervous system, they can help treat joint and mobility conditions.
When it comes to cannabis and hemp, we have made some pretty significant leaps.
We identified the cannabinoid THC in 1964, mapped the first body-producing endocannabinoid in 1990, and significantly enhanced our understanding of the endocannabinoid system in 1992.
Cannabinoid therapies have taken center stage when it comes to holistic health. There are hundreds of cannabinoids present in cannabis, most are non-psychoactive, and few have been heavily researched.
Cannabigerol (CBG) is present in many cannabis strains at low levels. We may be at the beginning of cannabinoid research. Here’s what we know about CBG so far.
The news on Brexit is ever-changing, so we will look at what’s going on in the UK now that they are doing things on their own terms.
The CBD and cannabis market has always been slow in the European Union, even before the UK’s divorce.